+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Parenteral Nutrition - Global Market Trajectory & Analytics

  • ID: 1882097
  • Report
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Allergan plc
  • Amanta Healthcare Ltd
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius KABI AG
  • ICU Medical Inc.
Global Parenteral Nutrition Market to Reach $7.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Parenteral Nutrition estimated at US$5.4 Billion in the year 2020, is projected to reach a revised size of US$7.2 Billion by 2027, growing at a CAGR of 4.2% over the analysis period 2020-2027. Single Dose Amino Acid Solution, one of the segments analyzed in the report, is projected to record a 4.7% CAGR and reach US$2.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Parenteral Lipid Emulsion segment is readjusted to a revised 4.7% CAGR for the next 7-year period.





The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 7.5% CAGR

The Parenteral Nutrition market in the U.S. is estimated at US$1.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 7.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.3% and 3.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Carbohydrates Segment to Record 3.8% CAGR

In the global Carbohydrates segment, USA, Canada, Japan, China and Europe will drive the 3.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$724.8 Million in the year 2020 will reach a projected size of US$908.4 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1 Billion by the year 2027, while Latin America will expand at a 4.7% CAGR through the analysis period.

Select Competitors (Total 20 Featured):
  • Allergan plc
  • Amanta Healthcare Ltd
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius KABI AG
  • Grifols International S.A.
  • ICU Medical Inc.
  • Otsuka Pharmaceutical Factory Inc.
  • Sichuan Kelun Pharmaceutical Co. Ltd.
  • Sino-Swed Pharmaceutical Corp. Ltd.
Frequently Asked Questions about the Global Market for Parenteral Nutrition

What is the estimated value of the Global Market for Parenteral Nutrition?

The Global Market for Parenteral Nutrition was estimated to be valued at $5.4 Billion in 2020.

What is the growth rate of the Global Market for Parenteral Nutrition?

The growth rate of the Global Market for Parenteral Nutrition is 4.2%, with an estimated value of $7.2 Billion by 2027.

What is the forecasted size of the Global Market for Parenteral Nutrition?

The Global Market for Parenteral Nutrition is estimated to be worth $7.2 Billion by 2027.

Who are the key companies in the Global Market for Parenteral Nutrition?

Key companies in the Global Market for Parenteral Nutrition include Allergan plc, Amanta Healthcare Ltd, B. Braun Melsungen AG, Baxter International Inc., Fresenius KABI AG, Grifols International S.A., ICU Medical Inc., Otsuka Pharmaceutical Factory Inc. and Sino.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allergan plc
  • Amanta Healthcare Ltd
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius KABI AG
  • ICU Medical Inc.

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Parenteral Nutrition: Providing Essential Nutrition through Intravenous Feeding
  • Recent Market Activity
  • Malnutrition Related to Chronic Medical Conditions Fuels Demand for PN Products
  • The Road Ahead
  • Developed Economies Lead, Developing Regions to Propel Future Growth
  • Single Dose Amino Acid Solutions - Major Share of PN Solutions Market
  • Competitive Landscape
  • Parenteral Nutrition Competitor Market Share Scenario Worldwide (in %): 2020 & 2029

2. FOCUS ON SELECT PLAYERS
  • Allergan plc (Ireland)
  • Amanta Healthcare Ltd (India)
  • B. Braun Melsungen AG (Germany)
  • Baxter International, Inc. (USA)
  • Fresenius KABI AG (Germany)
  • Grifols International S.A. (Spain)
  • ICU Medical, Inc. (USA)
  • Otsuka Pharmaceutical Factory, Inc. (Japan)
  • Sichuan Kelun Pharmaceutical Co., Ltd. (China)
  • Sino-Swed Pharmaceutical Corp. Ltd. (China)

3. MARKET TRENDS & DRIVERS
  • Clinical Nutrition Vital for Combating Malnutrition during Hospitalization
  • Increase in Healthcare Spending Bodes Well for Parenteral Nutrition Market
  • Rapidly Aging Demographics to Propel Demand for Parenteral Nutrition
  • Rising Incidence of Chronic Diseases to Propel Growth of Parenteral Nutrition Market
  • Cancer Patients - the Highest PN Users
  • Parenteral Nutrition: Critical for People with Gastrointestinal Disorders
  • Unrelenting Threat of HIV/AIDS Infection: An Opportunity for Parenteral Nutrition Market
  • Persistent Threat of HIV/AIDS - A Peek at Global HIV Statistics
  • Diabetes Mellitus: PN Therapy Indicated for Patients with Non-functional GI Tract
  • Global Diabetic Statistics - Opportunity Indicators
  • Rising Number of Premature Births Enhances Need for Parenteral Nutrition
  • Preterm Birth Statistics from WHO
  • Inadequate Physiological Development Raises Need for Tube Feeding in Infants
  • Nutritional Needs of Premature Infants: Mix of PN & EN Nutrition Emerges as Common Practice
  • Intravenous Therapy in Outpatient Settings to Boost Parenteral Nutrition Market
  • Growing Demand for Home Intravenous Nutritional Therapies
  • Rising Preference for Multi-Chamber Bags to Lower Cost of Parenteral Nutrition Therapy
  • Pre-mixed IV Nutrition: A Step towards Safer Medication Practices
  • Growing Demand for Low-Cost Parenteral Nutrition Solutions
  • Rising Popularity of Intravenous Vitamin C for Cancer Treatment
  • Increasing Demand for Peripheral Intravenous Nutrition
  • Iron Replacement Therapies - A Potential Market Segment
  • Popularity of TPN as Beauty Treatment Raises Ethical and Safety Concerns
  • Pharmaceutical Industry Participants Migrate from Concentrated Vials to Premixed Solutions
  • Vial Dilution and Potential Risks
  • Premixed Bags Present Efficient Delivery System
  • Switching from Vials to Premixed Bags
  • Challenges Confronting Production of Parenteral Products
  • Continuous Supply of Raw Material: Crucial for Production
  • Rising Preference for Enteral Nutrition: A Threat to Parenteral Nutrition Market
  • Infection Control: A Prime Concern in Parenteral Nutrition
  • Limiting Medication Errors - A Key Concern

4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
  • UNITED STATES
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • SPAIN
  • RUSSIA
  • REST OF EUROPE
  • ASIA-PACIFIC
  • AUSTRALIA
  • INDIA
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA

IV. COMPETITION
  • Total Companies Profiled: 20
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Allergan plc
  • Amanta Healthcare Ltd
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius KABI AG
  • Grifols International S.A.
  • ICU Medical Inc.
  • Otsuka Pharmaceutical Factory Inc.
  • Sichuan Kelun Pharmaceutical Co. Ltd.
  • Sino-Swed Pharmaceutical Corp. Ltd.
Note: Product cover images may vary from those shown